New eBook: The role of real-world evidence in FDA approvals. Download now.

Upcoming Events

Past Events

December 2, 2020

ACDRS Webinar Series

Role of real-world evidence in regulatory decision-making before, during, and after COVID

November 16, 2020

ICPE All Access

Applied sensitivity analysis

Sebastian Schneeweiss, M.D., Sc.D. Jeremy Rassen, Sc.D.

November 16, 2020

Virtual ISPOR Europe 2020

Comparison of external control arm critiques in regulatory and health technology assessment oncology submissions

November 9, 2020

ICPE All Access

Comparative effectiveness research

Sebastian Schneeweiss, M.D., Sc.D.

November 9, 2020

DIA Real-World Evidence Conference

The selection and use of external comparators for expedited drug development

Jeremy Rassen, Sc.D.

November 4, 2020

ICPE All Access

Advanced pharmacoepidemiology: Pharmacoepidemiologic methods used in COVID research

Jeremy Rassen, Sc.D.

October 26, 2020

Fortune Global Forum

What it takes: Thriving in the data age

Carolyn Magill

October 22, 2020

3rd Annual MarketsandMarkets RWD, Life Sciences Analytics, and Market Access Virtual Conference

Regulatory and HTA decision-making: Latest precedent and what’s ahead

October 15, 2020

ICPE All Access

Lessons learned from replicating clinical trials with real-world data

Sebastian Schneeweiss, M.D., Sc.D.

October 8, 2020

ICPE All Access

Propensity scores in pharmacoepidemiology

Jeremy Rassen, Sc.D.

October 7, 2020

ICPE All Access

Machine learning to optimize and automate confounding control in studies using high-dimensional health care data

Sebastian Schneeweiss, M.D., Sc.D.

September 24, 2020

World Pharma Pricing and Market Access Congress

RWE for regulatory and HTA decision-making: latest precedent and what’s ahead

September 17, 2020

Morgan Stanley Virtual Global Healthcare Conference

Fireside chat

Carolyn Magill

September 16, 2020

ICPE All Access

Multiple presentations

September 14, 2020

Virtual ISPOR Asia Pacific 2020

Access to personalized medicine: Challenges from single arm studies

Jeremy Rassen, Sc.D.

August 6, 2020

Webinar with McDermott Will & Emery LLP

Evolving opportunities and challenges for real-world evidence and data-powered solutions

Carolyn Magill

August 5, 2020

HTAi 2020 Virtual Annual Meeting

What does good look like? Evaluating decision-grade RWE

June 25, 2020

PCMG Live

COVID-19: Forces innovation! Speeding up the pace of change

Jeremy Rassen, Sc.D.

June 23, 2020

Webinar with HealthVerity

RWE and real-time insights: how to advance regulatory and commercial strategy in the COVID-19 era

Jeremy Rassen, Sc.D.

June 20, 2020

HTAi Annual Meeting 2020

What does good look like? Evaluating decision-grade real-world evidence

Jeremy Rassen, Sc.D.

June 17, 2020

DIA 2020 Virtual Global Annual Meeting

Combining multiple real-world data sources to maximize value

Jeremy Rassen, Sc.D.

June 8, 2020

BIO Digital 2020

Financing transformative therapies: Cross-sector perspective on value and payment

June 4, 2020

HealthEconomics.com webinar

How to build a leading-practice RWE program to inform innovative drug contracting and market access

Carolyn Magill

May 29, 2020

DIA Biostatistics Industry and Regulator Forum

A community of networks: Creating and leveraging a network of distributed data supporting medical product development

Jeremy Rassen, Sc.D.

May 19, 2020

Virtual ISPOR 2020

RWE guidance and frameworks: What elements are necessary to promote quality, transparency, and validity in real-world evidence

May 17, 2020

ISPOR 2020

Developing decision-grade real-world evidence

Jeremy Rassen, Sc.D. Sebastian Schneeweiss, M.D., Sc.D.

April 23, 2020

Informa webinar

Real-world evidence for regulatory decision-making

Jeremy Rassen, Sc.D. Sebastian Schneeweiss, M.D., Sc.D.

April 22, 2020

DIA Biostatistics Industry and Regulator Forum

A community of networks, creating, and leveraging a network of distributed data supporting medical product development

Jeremy Rassen, Sc.D.

April 16, 2020

WuXi Online Forum II on COVID-19

Harnessing our collective power

Carolyn Magill

April 2, 2020

eyeforpharma Barcelona Virtual 2020

Generate RWE pre-approval to inform regulatory decisions and expand access

Carolyn Magill

February 28, 2020

MIT Sloan Healthcare and BioInnovations Conference

Innovation showcase presentation

February 12, 2020

RWE Leaders Forum

Guest speaker session

Carolyn Magill

February 10, 2020

BIO CEO & Investor Conference

Commercialization strategies for communicating evidence of a therapy’s value

Carolyn Magill

February 9, 2020

HBS 17th Annual Health Care Conference

Lunch roundtable

January 14, 2020

J.P. Morgan 38th Healthcare Conference

WuXi global forum: “The shifting paradigm: From sick care to health care”

Carolyn Magill

January 13, 2020

W2O's 6th Annual Digital Health Luncheon at J.P. Morgan

Healthcare’s use of data and new data sources

Carolyn Magill

December 10, 2019

HIMSS & Health 2.0 Japan 2019

Keynote: Using real-world evidence to answer critical questions in health care

Jeremy Rassen, Sc.D.

December 10, 2019

Digital Healthcare Innovation Summit

Building a strong case with real-world evidence

Carolyn Magill

December 9, 2019

Longwood Annual Healthcare Leaders Meeting

Getting to drug approval

Carolyn Magill

December 6, 2019

16th Global Cardiovascular Clinical Trialists Forum

Real-world data to predict randomized trial results before they’re done: The RCT DUPLICATE initiative

December 3, 2019

eyeforpharma Webinar

Let’s talk about value: Use RWE to determine drug price and performance

Carolyn Magill

November 18, 2019

United States of Care 2019

Next generation challenges and opportunities in health care

Carolyn Magill

November 15, 2019

DIA Real World Evidence Conference

What’s next: Real-world evidence in the development and access of novel therapeutics

Jeremy Rassen, Sc.D.

November 12, 2019

Friends of Cancer Research Annual Meeting

Characterizing the use of external controls for augmenting randomized control arms and confirming benefit

Jeremy Rassen, Sc.D.

November 6, 2019

ISPOR Europe 2019

Big healthcare data — Endless opportunities for research and learning

Jeremy Rassen, Sc.D.

November 5, 2019

ISPOR Europe 2019

Are value assessment frameworks using RWE? A review of NICE and ICER psoriasis assessments

November 4, 2019

ISPOR Europe 2019

Transparency in RWE — Time for a unified approach

Sebastian Schneeweiss, M.D., Sc.D.

November 4, 2019

ISPOR Europe 2019

Themes in the design of pharmaceutical value-based contracts in the United States and Europe

November 4, 2019

ISPOR Europe 2019

Are we there yet? Using RWD for regulatory-grade external control arms

Jeremy Rassen, Sc.D.

November 2, 2019

ISPOR Europe 2019

Use of propensity scores in observational studies of treatment effects

Jeremy Rassen, Sc.D.

October 31, 2019

AMCP Nexus 2019

Using real-world evidence to design value-based contracts for the real world

October 30, 2019

HLTH - The Future of Healthcare

The 7 things smart companies do to close the gender gap

Carolyn Magill

October 28, 2019

HLTH - The Future of Healthcare

Real-world evidence for value-based care

Carolyn Magill

October 24, 2019

2nd Annual MarketsandMarkets Real-World Data and Life Science Analytics Congress

Panel discussion: Pros & cons of real-world evidence framework by FDA. Perspective from different stakeholders — providers & payers

October 18, 2019

2019 Wharton Health Care Conference on Artificial Intelligence

Real-world evidence case study

Carolyn Magill

October 16, 2019

Connected Health Conference

How real-world evidence will facilitate the shift toward value-based care

October 11, 2019

ISPOR Summit 2019

Transparency in RWE — Time for a unified approach

Sebastian Schneeweiss, M.D., Sc.D.

October 3, 2019

Duke-Margolis: Developing Real-World Data and Evidence to Support Regulatory Decision-Making

Methodological and analytical considerations for observational studies

Sebastian Schneeweiss, M.D., Sc.D.

October 2, 2019

Future of Health

Digital Health 150

Jeremy Rassen, Sc.D.

September 18, 2019

Friends of Cancer Research 8th Annual Blueprint for Breakthrough Forum

The future of real-world evidence: Informing regulatory and payer decisions

Jeremy Rassen, Sc.D.

September 18, 2019

IMPACCT: RWE

Real-world evidence to support regulatory submissions

Sebastian Schneeweiss, M.D., Sc.D.

September 17, 2019

Health 2.0

The keys to outcome and evidence-based care

Carolyn Magill

August 28, 2019

35th ICPE

Causal inference in pharmacoepidemiology

Sebastian Schneeweiss, M.D., Sc.D.

August 28, 2019

35th ICPE

Where should I submit my paper? Applying machine learning to enhance communication of medical research

Jeremy Rassen, Sc.D.

August 27, 2019

35th ICPE

Inferring mortality in claims data

August 26, 2019

35th ICPE

Poster, podium, and symposia presentations

Jeremy Rassen, Sc.D. Sebastian Schneeweiss, M.D., Sc.D.

August 26, 2019

35th ICPE

Reproducibility of a population-based cohort study characterizing newly diagnosed multiple myeloma patients in the UK using an EHR database

August 26, 2019

35th ICPE

Incidence of Fournier’s gangrene in type 2 diabetic patients using second-line antidiabetic drugs

August 26, 2019

35th ICPE

The ascension of real-world evidence: Can (and should) we establish thresholds for validity?

Sebastian Schneeweiss, M.D., Sc.D.

August 26, 2019

35th ICPE

What does replicable and robust non-randomized database evidence look like?

Jeremy Rassen, Sc.D.

August 26, 2019

35th ICPE

Clinical outcomes in patients with type 2 diabetes newly initiating SGLT2 or DPP4 inhibitors

August 25, 2019

35th ICPE

Propensity scores in pharmacoepidemiology

Jeremy Rassen, Sc.D.

August 25, 2019 in Philadelphia, PA

35th ICPE

Applied sensitivity analyses in pharmacoepidemiology database studies

Jeremy Rassen, Sc.D.

July 23, 2019

eyeforpharma Webinar

The real-world evidence regulatory evolution: How to use RWE to augment RCTs and advance the drug development paradigm

Jeremy Rassen, Sc.D. Sebastian Schneeweiss, M.D., Sc.D.

June 25, 2019 in San Diego, CA

DIA Global Annual Meeting

Use of real-world evidence to support regulatory decision-making: First-year findings from the RCT-DUPLICATE project

Jeremy Rassen, Sc.D.

June 24, 2019 in San Diego, CA

DIA Global Annual Meeting

Using real-world data to develop a safety monitoring program and ensure pre- and post-market continuity

Jeremy Rassen, Sc.D.

June 11, 2019

5th Annual d.health Summit: Aging Americans Innovation Conference

Facilitated discussion

Carolyn Magill

June 7, 2019 in San Fransisco, CA

American Diabetes Association

RWD analyses for regulatory decision-making

Sebastian Schneeweiss, M.D., Sc.D.

June 3, 2019 in Philadelphia, PA

BIO 2019

Real-world data external controls panel

Jeremy Rassen, Sc.D.

May 22, 2019

ISPOR 2019

Quantifying the opportunity to reduce total cost of care through targeted medication prioritization and adherence improvement in diabetes

Jeremy Rassen, Sc.D. Sebastian Schneeweiss, M.D., Sc.D.

May 22, 2019

ISPOR 2019

Replicable and robust database evidence: What does it look like?

Jeremy Rassen, Sc.D.

May 20, 2019

ISPOR 2019

Replication of randomized controlled trials using real-world data: What does good look like?

Sebastian Schneeweiss, M.D., Sc.D.

May 18, 2019 in New Orleans, LA

ISPOR 2019

De-Risking Risk Sharing: Enabling Payer-Pharma Interactions and Value-based Contracting with RWE

Jeremy Rassen, Sc.D. Sebastian Schneeweiss, M.D., Sc.D.

May 18, 2019 in New Orleans, LA

ISPOR 2019

Use of propensity scores in observational studies of treatment effects

Jeremy Rassen, Sc.D.

April 29, 2019 in Grapevine, TX

2019 Blue Cross Blue Shield National Summit

Applying rapid-cycle analytics of real-wolrd data to reduce medical costs and improve outcomes among high-risk members: case studies in diabetes and inflammatory bowel disease

April 24, 2019 in Washington, DC

12th Annual FDA/AdvaMed Medical Devices & Diagnostics Statistical Issues Conference

An approach for incorporating real-world evidence into regulatory decision-making

April 17, 2019

eyeforpharma Philadelphia

Panel: A strategic cross-functional approach to evidence generation

April 10, 2019

Health Evolution Summit

Corporate Venture Group panel

Carolyn Magill

April 9, 2019 in Copenhagen, Denmark

Danish Epidemiological Society Spring Meeting 2019

Automated data adaptive analytics for electronic healthcare data to study causal treatment effects

Sebastian Schneeweiss, M.D., Sc.D.

April 6, 2019 in Rome, Italy

ISPE's 2019 Mid-Year Meeting

Scientific perspectives on biologic and biosimilar use

Sebastian Schneeweiss, M.D., Sc.D.

April 3, 2019 in San Diego, CA

FORTUNE Brainstorm Health 2019

Lunch session

Carolyn Magill

April 2, 2019

Healthcare Costs Innovation Summit

The value-based care movement

Carolyn Magill

April 2, 2019

Harvard-MIT CRS Regulatory Science Symposium 2019

Real-world evidence sessions

March 28, 2019 in Washington, D.C.

2019 Health Datapalooza

Rapid fire: Real world evidence

Carolyn Magill

March 25, 2019 in San Diego, CA

AMCP Managed Care & Specialty Pharmacy Annual Meeting

Using rapid-cycle analytics of real-world data to manage high risk, high cost patients

March 21, 2019

International Society for Pharmacoepidemiology (ISPE) Webinar

Visual pharmacoepidemiology

Jeremy Rassen, Sc.D.

March 20, 2019

Pharmaceutical Executive Webinar

Using real-world evidence for U.S. regulatory decision-making: What pharma needs to know

Carolyn Magill Sebastian Schneeweiss, M.D., Sc.D.

March 12, 2019 in Barcelona

RWE Europe at eyeforpharma Barcelona

Understand the acceptability of RWE across global regulatory decision-making

Jeremy Rassen, Sc.D.

February 6, 2019 in Vienna, Austria

DIA Europe 2019

Confidence in real world data

Sebastian Schneeweiss, M.D., Sc.D.

February 4, 2019 in Washington, DC

National Health Policy Conference

Future directions in regulatory policy: the role of real-world evidence

Jeremy Rassen, Sc.D.

January 29, 2019 in Washington, DC

DIA's Pharmacovigilance and Risk Management Strategies Conference

When and how can RWD analyses support regulator decision making

Sebastian Schneeweiss, M.D., Sc.D.

January 22, 2019 in Washington, D.C.

Duke-Margolis Center for Health Policy

Unpacking real-world data curation: Principles and best practices to support transparency and quality

Jeremy Rassen, Sc.D.

January 17, 2019 in 11a.m. - 12p.m.

International Society for Pharmacoepidemiology (ISPE) Webinar

A decade of experience with high-dimensional propensity scores

Sebastian Schneeweiss, M.D., Sc.D.

January 16, 2019 in London, UK

Symposium on Accessibility and Impact of High Value Medicines

Evidences of access impact: Conclusions from the satellite workshop

Sebastian Schneeweiss, M.D., Sc.D.

January 15, 2019 in London, UK

Symposium on Accessibility and Impact of High Value Medicines

How can observational studies reproduce causality assessment

Sebastian Schneeweiss, M.D., Sc.D.

January 7, 2019 in San Francisco, CA

37th Annual J.P. Morgan Healthcare Conference

Digital health panel

Carolyn Magill

November 15, 2018 in Washington, DC

U.S. News Healthcare of Tomorrow 2018

Next steps for value-based care

Carolyn Magill

November 14, 2018 in Barcelona, Spain

ISPOR Europe 2018

Addressing challenges to open science: Data sharing, replication, and robustness of evidence from real world data

Sebastian Schneeweiss, M.D., Sc.D.

November 10, 2018 in Barcelona, Spain

ISPOR Europe 2018

Use of propensity scores in observational studies of treatment effects

Jeremy Rassen, Sc.D.

November 7, 2018 in Philadelphia, PA

8th Annual eyeforpharma Value Summit

The future of pharma requires a value shift

November 7, 2018 in Montreal, Canada

CNODES Semi-Annual Meeting

Pharmacoepidemiology for regulatory decision making and the importance of analytic platforms

Sebastian Schneeweiss, M.D., Sc.D.

November 5, 2018 in San Francisco, CA

Real World Evidence Conference

Non-interventional studies: Study design considerations and current applications

Sebastian Schneeweiss, M.D., Sc.D.

October 28, 2018 in Xi'an, China

ACPE 2018

Real world evidence or clinical trials? Which should I believe?

Jeremy Rassen, Sc.D.

October 27, 2018 in Xi'an, China

ACPE 2018

Advanced analytic methods in pharmacoepidemiology

Jeremy Rassen, Sc.D.

October 25, 2018 in Boston, MA

Real-World Insights & Life Science Analytics Congress

Effective use of real-world data analytics across the life cycle: Data, analytics, people, organizations

Sebastian Schneeweiss, M.D., Sc.D.

October 25, 2018 in Boston, MA

Real-World Insights & Life Science Analytics Congress

Bringing two worlds together

October 23, 2018 in Boston, MA

20 years of DoPE

From better prediction to transparent outcome evaluation with advanced analytics

Jeremy Rassen, Sc.D.

October 23, 2018 in Boston, MA

20 years of DoPE

Real-world data in the peri-approval space

Sebastian Schneeweiss, M.D., Sc.D.

October 18, 2018 in San Francisco, California

BIO Investor Forum

How real-world evidence can improve clinical trial productivity

Jeremy Rassen, Sc.D.

October 16, 2018 in Toronto, Canada

Fortune Global Forum 2018

Big data: Transforming global health care

Carolyn Magill

September 18, 2018 in Santa Clara, CA

Health 2.0

One size does not fit all: Advances in precision health and medicine

September 13, 2018 in Bordeaux, France

University of Bordeaux

Data-adaptive methods for causal inference, automation, and the rise of analytic platforms in pharmacoepidemiology

Sebastian Schneeweiss, M.D., Sc.D.

August 24, 2018 in Prague, Czech Republic

34th ICPE

Applied sensitivity analyses in pharmacoepidemiology database studies

Sebastian Schneeweiss, M.D., Sc.D.

August 23, 2018 in Prague, Czech Republic

34th ICPE

Propensity scores in pharmacoepidemiology

Jeremy Rassen, Sc.D.

August 23, 2018 in Prague, Czech Republic

34th ICPE

Advanced topics in PE: Healthcare database analyses for regulatory decision making

Sebastian Schneeweiss, M.D., Sc.D.

August 22, 2018 in Prague, Czech Republic

34th ICPE

Comparative effectiveness research: Real-world evidence in health technology assessment

Sebastian Schneeweiss, M.D., Sc.D.

June 29, 2018 in Stockholm, Sweden

Karolinska Institutet

Real world data analyses for regulatory decision making – a global opportunity

Sebastian Schneeweiss, M.D., Sc.D.

June 20, 2018 in London, England

Drug Safety Research Unit

Big data for pharmacovigilance

Jeremy Rassen, Sc.D.

June 6, 2018

d.health Summit

Leveraging real-world data to optimize value-based care & improve health outcomes

Carolyn Magill

May 19, 2018 in Baltimore, MD

ISPOR 2018

Use of propensity scores in observational studies of treatment effects

Jeremy Rassen, Sc.D.

May 3, 2018 in Rockville, MD

2018 Accelerating Anticancer Agent Development and Validation (AAADV) Workshop

Examination of supplemental indication in cardiology using real-world data

Sebastian Schneeweiss, M.D., Sc.D.

April 27, 2018

Health Datapalooza

Taming the life sciences data beast

Carolyn Magill

April 26, 2018 in Washington, DC

Duke-Margolis Center for Health Policy

Workshop on real-world data quality

Sebastian Schneeweiss, M.D., Sc.D.

March 29, 2018 in Washington, DC

Duke-Margolis Center for Health Policy

Workshop on the regulatory applications of observational studies

Sebastian Schneeweiss, M.D., Sc.D.

March 24, 2018 in Orlando, FL

ASCPT 2018

Using complex healthcare databases to evaluate the safety and effectiveness of newly marketed medications

Sebastian Schneeweiss, M.D., Sc.D.

March 6, 2018 in Washington, DC

The National Academies of Sciences, Engineering, and Medicine Workshop

Healthcare database analyses of medical products for regulatory decision-making

Sebastian Schneeweiss, M.D., Sc.D.

February 15, 2018 in Washington, DC

National Institutes of Health

Gadolinium Deposition: What We Know and Don’t Know

Sebastian Schneeweiss, M.D., Sc.D.

January 26, 2018 in Boston, MA

American Journal of Law & Medicine Symposium

Developing Real World Evidence Fit for Regulatory Decision Making

Sebastian Schneeweiss, M.D., Sc.D.

January 21, 2018 in Beijing, China

CFDA China Center for Food & Drug International Exchange Conference

Transforming big, real-world data for decision-making about medical treatments

Jeremy Rassen, Sc.D.

December 13, 2017 in Cambridge, MA

NEWDIGS​ at MIT

Driving Value for Patients from Real World Evidence: Snapshots of Evolving Ecosystems

Sebastian Schneeweiss, M.D., Sc.D.

December 11, 2017 in London, UK

EMA 2017

Common Data Models for Regulatory Decision Making

Sebastian Schneeweiss, M.D., Sc.D.

October 18, 2017 in New York, NY

World Economic Forum

Value in healthcare

Sebastian Schneeweiss, M.D., Sc.D.

October 16, 2017 in Liverpool, UK

ISOP Annual Meeting

Use of big data in drug safety applications

Jeremy Rassen, Sc.D.

September 21, 2017 in Boston, MA

Real-World Analytics Summit

Panel Discussion: The Uptake of Real-World Data Analytics

Sebastian Schneeweiss, M.D., Sc.D.

August 28, 2017

International Society of Biopharmaceutical Statistics Annual Meeting

Generating Real World Evidence that is Fit For Decision Making

Sebastian Schneeweiss, M.D., Sc.D.

August 23, 2017 in Montréal, Quebec

ISPE Annual Meeting

ISPE: Course on Propensity Scores

Jeremy Rassen, Sc.D.

July 29, 2017

Joint Statistical Meeting

Real world evidence to support accelerated approval processes

Sebastian Schneeweiss, M.D., Sc.D.

The Evidence Digest

Subscribe to our newsletter for insights and updates on research and applications for real-world evidence in life sciences and value-based health care.

arrowcalendarchevronclosecollapsecountdownfacebookflickrinstagramlinelinkedinlocationpinsearchsocialtwitteryoutube